Clinical trial
Investigation and Early Risk Prediction of Acute Kidney Injury Caused by Iodinated Contrast Agents: Development of CI-AKIDPi Model Based on Interpretable Deep Learning
NCT06596785 is registered in ClinicalTrials.gov with Xiao Li,MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation and Early Risk Prediction of Acute Kidney Injury Caused by Iodinated Contrast Agents: Development of CI-AKIDPi Model Based on Interpretable Deep Learning
- Lead sponsor
- Xiao Li,MD
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 1, 2024
- Completion date
- June 1, 2025
- Enrollment
- 2,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aki - acute kidney injury